dots health software glp-1 ACCESS Program In U.S., GLP-1 Usage Reaches

The most commonly reported adverse events in TRIUMPH-4 included nausea (3843% at higher doses vs

Frias JP, Nauck MA, Van J, Benson C, Bray R, Cui X, Milicevic Z, Urva S, Haupt A, Robins DA

GLP-1 therapy isnt just about weight loss, its about creating healthier habits that last

In the published Phase 2 obesity trial, people taking retatrutide 12mg lost an average of 24.2% of their body weight at 48 weeks, compared with 2.1% with placebo

Document your impact Beyond medical records, document how the injury has affected your life

The Body Program includes FDA-approved GLP-1s like Wegovy, Ozempic, and Zepbound, as well as compounded options (not FDA-approved, not available in some states) if insurance wont cover the brand names